News & Updates
Filter by Specialty:
Trastuzumab deruxtecan improves PFS in metastatic breast cancer, but ups ILD risk
Treatment with trastuzumab deruxtecan (T-DXd) demonstrates efficacy in patients with metastatic hormone receptor-positive/human epidermal growth factor receptor 2-negative (HR+/HER2–) breast cancer but may result in adverse events, such as interstitial lung disease (ILD), suggests a study.
Trastuzumab deruxtecan improves PFS in metastatic breast cancer, but ups ILD risk
18 Nov 2024
What prevents women with postnatal depression from seeking help?
A Singapore study has recently described the personal motivations of women who are at risk of postnatal depression for seeking treatment.
What prevents women with postnatal depression from seeking help?
18 Nov 2024
Sacituzumab govitecan improves survival in advanced breast cancer
Treatment with sacituzumab govitecan (SG), a novel antibody-drug conjugate, provides survival benefits in women diagnosed with hormone receptor-positive/human epidermal growth factor receptor 2-negative (HR+/HER2–) breast cancer, reports a study.
Sacituzumab govitecan improves survival in advanced breast cancer
18 Nov 2024
Visual impairment is mainly caused by cataract, glaucoma and diabetic retinopathy in older persons and untreated refractive error in children.
A study in University of Malaya Medical Centre (UMMC) underscored the need for early detection of visual impairment in preventing blindness in every age group.
